Dobutamine/levosimendan/milrinoneLack of efficacy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2014卷 / 1期

关键词：

D O I：

10.1007/s40278-024-61667-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：239 / 239

相关论文

共 50 条

[31] Survival after levosimendan compared to dobutamine
Huang, L
Sun, SJ
Cammarata, G
Tang, WC
Weil, MH
CIRCULATION, 2004, 110 (17) : 531 - 531
[32] Imatinib/milrinoneLack of efficacy : case report
Reactions Weekly, 2024, 2021 (1) : 245 - 245
[33] Esmolol/milrinoneLack of efficacy: case report
Reactions Weekly, 2020, 1827 (1) : 142 - 142
[34] Levosimendan vs dobutamine in septic shock
Alhashemi, Jamal A.
Alotaibi, Qamar A.
Abdullah, Ghadah M.
Shalabi, Sanaa A.
JOURNAL OF CRITICAL CARE, 2009, 24 (03) : e14 - e15
[35] Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis
Jaguszewski, Milosz J.
Gasecka, Aleksandra
Targonski, Radoslaw
Filipiak, Krzysztof J.
Szarpak, Lukasz
CARDIOLOGY JOURNAL, 2021, 28 (03) : 492 - 493
[36] Levosimendan versus dobutamine in septic shock
JA Alhashemi
Q Alotaibi
Critical Care, 13 (Suppl 1):
[37] Furosemide/milrinoneLack of efficacy: case report
Reactions Weekly, 2021, 1839 (1) : 145 - 145
[38] Epoprostenol/milrinoneLack of efficacy: case report
Reactions Weekly, 2025, 2050 (1) : 226 - 226
[39] Epinephrine/MilrinoneLack of efficacy : case report
Reactions Weekly, 2024, 2019 (1) : 181 - 181
[40] Epoprostenol/milrinoneLack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 240 - 240

← 1 2 3 4 5 →